Kerala

AOC

Goods

Medicines

Re-tender for the procurement of Anti cancer drugs for the year 2025-26

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 30 Jul 2025Closed

Bids

Item Wise

6 Bids5 Jun 2026

#	Company	Amount	Rank	Status
1	L1₹1 LAccepted-AOC NA \| NA \| NA \| 121004	₹1 L	L1	Accepted-AOC DETAILS IN NOTICE
2	L1₹1 LAccepted-AOC	₹1 L	L1	Accepted-AOC DETAILS IN NOTICE
3	L1₹1 LAccepted-AOC 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 \| HYDERABAD \| HYDERABAD \| TELANGANA \| 500016	₹1 L	L1	Accepted-AOC DETAILS IN NOTICE
4	L1₹1 LAccepted-AOC	₹1 L	L1	Accepted-AOC DETAILS IN NOTICE
5	L1₹1 LAccepted-AOC	₹1 L	L1	Accepted-AOC DETAILS IN NOTICE

BoQ Line Items

Line Items (7)

Sl No	Description	Qty	Unit	Fresenius Kabi Oncology Limited L3	Emcure Pharmaceuticals Ltd L4	Dr.Reddys LAboratories Limited L5	BRUCK PHARMA PVT LTD L1	Beta Drugs Limited L2
1.00	CARFILZOMIB INJ 30 mg	996	Vial	-	-	16,327 ₹1,959.24	-	-
2.00	ERIBULIN INJ 0.44 mg/ml	325	2 ml Vial	-	6,500 ₹780	-	-	-
3.00	LAPATINIB TAB IP 250 mg	37,731	1 No	-	-	-	49 ₹2.45	51 ₹2.55
4.00	OCTREOTIDE INJ 30 mg	386	PFS	-	-	-	-	-
5.00	OCTREOTIDE INJ 20 mg	88	PFS	-	-	-	-	-
6.00	PACLITAXEL NANOPARTICLE INJ 100 mg	1,719	Vial	3,858 ₹462.96	-	-	-	-
7.00	PROTEIN BOUND PACLITAXEL INJ 100 mg	4,344	Vial	-	-	-	-	1,338 ₹160.56

Tender Value

Refer Docs

EMD Value

₹50,000

Closing Date

30 Jul 2025, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

KMSCL, THYCAUD

Work Description

Re-tender for the procurement of Anti cancer drugs for the year 2025-26

Tender Information

Tender ID

2025_KMSCL_777250_1

Reference Number

KMSCL/ED/ACD/RT/2025/021

Tender Type

Open Tender

Product Category

Medicines

Period of Work

365 days

Location

Thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

please refer tender document

Documents Required

22 documents required · 22 mandatory

Fee/PreQual/Technical

RequiredCheck list in Anx 1 (.pdf)

RequiredDocumentry proof that the firm has claimed for exemption from submitting EMD and TDcost (.pdf)

RequiredThe details of offline EMD submitted as DD/BG, if applicable (.pdf)

RequiredThe details of Reinspection fee as per sl no 4 of Anx 1 (.pdf)

RequiredThe details of factory inspection as per sl no 5 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 6 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 7 of Anx 1 (.xls)

RequiredNotary attested copy of annual turnover statement as per sl no 8 of Anx 1 (.pdf)

RequiredNotary attested copy of valid import license as per sl no 10 of Anx 1 (.pdf)

RequiredNotary attested copies of product wise market standing certificate as per sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy of valid license for the sale of drugs as per sl no 12 of Anx 1 (.pdf)

RequiredNotary attested copy of valid WHO-GMP certificate as per sl no 13 of Anx 1 (.pdf)

RequiredNotary attested copy of current Non conviction certificate as per sl no 14 of Anx 1 (.pdf)

RequiredNotary attested performance stmt as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of Power of Attorney as per sl no 16 of Anx 1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 17 of Anx 1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 18 of Anx 1 (.pdf)

RequiredNotary attested copy of Audited Baalnce sheets and P and L stmt as per sl no 19 of Anx 1 (.pdf)

RequiredNotary attested details of technical personnel as per sl no 20 of Anx 1 (.pdf)

RequiredNotary attested details of the bidder as per sl no 21of Anx 1 (.pdf)

RequiredNotary attested manufacturing license as per sl no 9 of ANx 1 (.pdf)

Finance

Requiredprice bid format (.xls)

Fee & Financial Details

Tender Fee Amount

₹9,600

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹50,000

EMD Fee Exemption Allowed

Yes

Pre-Bid Meeting

Meeting Place

online platform

Important Dates

Last Activity

5 Jun 2026

Published

16 Jul 2025

Bid Opening

1 Aug 2025

Download Starts

16 Jul 2025

Download Ends

30 Jul 2025

Submission Starts

16 Jul 2025

Clarification Period

16 Jul 2025 - 30 Jul 2025

Pre-Bid Meeting

21 Jul 2025

BOQ Preview

•

CARFILZOMIB INJ 30 mg

•

ERIBULIN INJ 0.44 mg/ml

•

LAPATINIB TAB IP 250 mg

•

OCTREOTIDE INJ 30 mg

•

OCTREOTIDE INJ 20 mg

•

PACLITAXEL NANOPARTICLE INJ 100 mg

•

PROTEIN BOUND PACLITAXEL INJ 100 mg

•

Beta Drugs Limited (BID ID -2262224)

•

Fresenius Kabi Oncology Limited (BID ID -2253519)

•

Emcure Pharmaceuticals Ltd (BID ID -2265091)

•

Dr.Reddys LAboratories Limited (BID ID -2266446)

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.06 MB

Technical Evaluation

tech_eval.pdf

PDF

Financial Bid Opening

boq_comp_chart.xlsx

xlsx

Financial Evaluation

fin_eval.pdf

PDF

Award of Contract

aoc.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

Ready to Participate?

Download all tender documents and submit your bid